Medtronic Spinal Cord Stimulator Lawsuit

Medtronic spinal cord stimulator lawsuits allege that certain Intellis, Vanta, Restore, and related spinal cord stimulator systems malfunctioned or caused serious injuries after implantation.

A patient may receive a spinal cord stimulator implanted after medications, physical therapy, surgery, and other treatments fail to provide adequate relief.

The device sends electrical stimulation near the spinal cord to modify or block pain signals, but some patients report unsatisfactory pain relief, abnormal stimulation, or worsening symptoms after receiving the permanent implant.

Recent complaints allege that Medtronic introduced substantial changes to later device generations through supplements to the original regulatory approval without sufficient new clinical testing.

Plaintiffs claim that changes involving leads, batteries, charging functions, software, programming, and stimulation waveforms contributed to device failure or other spinal cord stimulator complications.

Patients pursuing a defective medical device lawsuit may allege that a Medtronic system caused burning sensations, painful electrical shocks, lead migration, loss of stimulation, or new nerve pain.

More serious claims may involve neurological injury, weakness, mobility limitations, or loss of bowel or bladder control.

When reprogramming does not correct the problem, patients may require revision procedures, replacement of device components, complete device removal, or multiple surgeries.

Each claim depends on the exact Medtronic system implanted, the alleged defect, the patient’s medical history, and evidence connecting the device to the resulting injuries.

Common allegations in Medtronic spinal cord stimulator lawsuits include:

• Defective design or manufacturing that caused abnormal stimulation or device failure
• Inadequate testing of later systems and post-approval device modifications
• Failure to warn patients and physicians about known or foreseeable risks
• Lead migration, lead fracture, or loss of effective stimulation
• Battery, charging, programming, or wireless communication problems
• Painful electrical shocks, burning sensations, and new nerve pain
• Unsatisfactory pain relief or worsening of the original pain condition
• Neurological injuries affecting mobility or bowel and bladder control
• Revision surgery, component replacement, or complete device removal
• Misrepresentations concerning device safety, performance, or expected pain relief

Medtronic Spinal Cord Stimulator Lawsuit Status

Medtronic lawsuits are proceeding separately and are not included in Boston Scientific MDL 3181.

Six Medtronic actions were reported to the JPML during the original spinal cord stimulator litigation, but the Panel declined to create one industrywide MDL involving competing medical device companies because their products, regulatory histories, records, and alleged defects involve different factual questions.

No nationwide Medtronic spinal cord stimulator MDL has been established as of writing.

Patients who suffered complications may still file individual claims based on the Medtronic device implanted, the alleged defect, the medical treatment required, and the applicable filing deadline.

Medtronic is one of the longest-established spinal cord stimulator manufacturers, with its original Itrel spinal cord stimulation system receiving FDA approval in 1984.

Medtronic systems are indicated as an aid in managing chronic, intractable pain of the trunk or limbs, including certain forms of chronic back pain.

After a successful trial, a patient may receive a permanent spinal cord stimulator that uses implanted leads and a pulse generator to send electrical signals near the spinal cord.

The systems are intended to reduce pain and provide a continuing therapeutic benefit, although results vary among patients.

Current Medtronic spinal cord stimulation systems include:

• Intellis Pro: A rechargeable system used to manage certain types of chronic, intractable pain.
• Vanta: A recharge-free system with programmable stimulation and position-responsive AdaptiveStim technology.
• Inceptiv: A rechargeable closed-loop system that senses neural responses and automatically adjusts stimulation in real time.

Older medical records may identify Medtronic systems such as Restore, RestoreSensor, Synergy, or Itrel, along with Pisces, Specify, or Vectris leads.

FDA records show that those systems and components belong to the same Medtronic regulatory product line.

Identifying the exact system, pulse generator, and leads is important when evaluating allegations involving device malfunction, battery or charging problems, abnormal stimulation, MRI restrictions, or loss of therapeutic benefit.

Patients can usually find that information on an implant card, operative report, billing record, or follow-up programming record.

Medtronic Spinal Cord Stimulator Recalls and Safety Actions

FDA records identify multiple Class II recalls and medical device corrections involving Medtronic spinal cord stimulator systems, programmers, and charging equipment.

The actions have addressed problems involving battery life, device communication, reprogramming, cardioversion damage, and unintended heating during charging.

A recall does not mean that every Medtronic spinal cord stimulator is defective, and some actions affected only specific models, serial numbers, accessories, or geographic markets.

Notable Medtronic spinal cord stimulator recalls and safety actions include:

• 2024 Vanta battery-life recall: Medtronic initiated a Class II recall involving 11,789 Vanta Model 977006 implantable neurostimulators distributed worldwide. The FDA record states that battery life could deplete faster than physicians or patients expected, potentially requiring outpatient reprogramming or surgical replacement earlier than anticipated.
• 2023 Vanta cardioversion recall: A Class II recall involving 3,791 Vanta devices addressed the possibility that a cardioversion procedure could damage the implant’s electronics and leave the system unresponsive. Medtronic had received two complaints involving the issue, both of which resulted in explant procedures.
• 2022 Vanta communication recall: Medtronic recalled 1,021 Vanta implantable neurostimulators because affected devices could fail to communicate with the clinician or patient programmer, potentially preventing therapy adjustments.
• 2024 Intellis reprogramming recall: The FDA classified an action involving one Intellis AdaptiveStim Model 97715 device distributed in the United Kingdom after the implant became unable to be reprogrammed. The limited scope should be stated clearly rather than treating the action as a broad Intellis recall.
• 2021 Intellis recharger recall: A Class II recall covered all serial numbers of the Intellis Model 97755 Recharger because of the potential for unintended heating while charging Intellis Models 97715 and 97716.

Medtronic has also issued safety communications involving older Restore systems, including rapid battery depletion that could interrupt therapy, and a 2014 labeling update addressing reports of epidural mass causing spinal cord compression.

Spinal cord stimulators are implanted devices used to manage chronic pain when other treatments have not provided adequate relief.

After a spinal cord stimulator is installed, leads positioned near the spinal cord deliver programmed electrical stimulation intended to alter pain signaling.

Some patients experience complications when the leads move, the battery or programmer fails, or the system produces abnormal stimulation.

A defective device may cause new or worsening pain, loss of therapy, infection, nerve injury, or the need for revision surgery.

More serious reported outcomes include weakness, impaired mobility, loss of bowel control, and other neurological symptoms.

In rare cases, patients allege severe electrical burns, permanent injury, or complications requiring complete device removal.

Spinal cord stimulator injuries and complications may include:

• Lead migration or lead fracture
• Painful electrical shocks or jolting sensations
• Burning sensations or internal tissue damage
• Loss of stimulation or inadequate pain relief
• New or worsening chronic pain
• Battery, charging, or programming failure
• Infection at the implant or surgical site
• Nerve damage, weakness, or numbness
• Impaired mobility or paralysis
• Loss of bowel or bladder control
• Dural puncture or cerebrospinal fluid leak
• Revision surgery to reposition or replace components
• Complete device removal
• Multiple surgeries and extended recovery
• Permanent disability or reduced quality of life

The severity and cause of these complications vary depending on the device, implantation procedure, patient condition, and treatment history.

Some problems may improve through reprogramming, while others require surgery to revise or remove the system.

A reported complication does not automatically establish that the spinal cord stimulator was defective or caused the injury.

Medical records, imaging, programming history, and device information may help determine whether the implant contributed to the patient’s symptoms.

You may qualify for a spinal cord stimulator lawsuit if you received an Intellis, Vanta, Inceptiv, Restore, or another Medtronic system and later developed serious complications.

Potential claims may involve painful electrical stimulation, lead migration, infection, loss of pain relief, nerve damage, or problems involving the implantable pulse generator.

A claim may be stronger when the complications required revision surgery, component replacement, or complete device removal.

Although modern spinal cord stimulators can provide relief for some patients, lawsuits allege that certain Medtronic systems malfunctioned or caused new injuries after implantation.

If you had a Medtronic spinal cord stimulator installed, preserve your implant card, operative report, imaging, programming records, and follow-up treatment notes.

Product identification is important because different medical device manufacturers use separate systems, components, and regulatory histories.

Attorneys may also examine whether Medtronic adequately tested the device and adequately warned patients and physicians about the risks associated with malfunction, abnormal stimulation, and additional surgery.

Eligibility ultimately depends on the device involved, the medical evidence connecting it to the injury, and the filing deadline that applies.

Gathering Evidence for a Spinal Cord Stimulator Lawsuit

Evidence in Medtronic medical device litigation should identify the implanted system, document how it performed, and connect the alleged malfunction to the patient’s injuries.

Operative reports, implant cards, imaging, programming history, and revision or removal records may show whether an Intellis, Vanta, Inceptiv, or another Medtronic system contributed to severe pain, abnormal stimulation, or additional treatment.

Spinal cord stimulator lawyers may also review charging records, device interrogation reports, physical therapy notes, and symptom documentation to determine how the patient’s condition changed after implantation.

Potential evidence may include:

• Operative reports from the original implantation procedure
• Implant records identifying the Medtronic system used
• Product identification cards
• Model and serial number information
• Billing records identifying the implanted device
• Records showing whether the system was Intellis, Vanta, or Inceptiv
• Imaging showing lead migration or other device issues
• Programming and reprogramming history
• Charging-related records for rechargeable spinal cord stimulators
• Revision surgery records
• Explant or removal records
• Symptom documentation from before and after implantation
• Physical therapy records
• Follow-up treatment notes describing ineffective pain relief, worsening symptoms, or abnormal stimulation

Damages in Spinal Stimulator Lawsuits

Damages in Medtronic spinal cord stimulator cases may include compensation for medical costs, lost income, physical pain, emotional distress, and reduced quality of life.

Claims involving revision surgery, complete device removal, permanent nerve damage, or long-term disability may have greater potential value.

The amount available depends on the device involved, the severity of the injury, the treatment required, and the lasting effect on the patient’s ability to work and complete daily activities.

No settlement or verdict is guaranteed, and each claim must be evaluated based on its own medical evidence and damages.

Potential damages may include:

• Past medical expenses
• Future medical expenses
• Revision surgery costs
• Explant or removal surgery costs
• Other follow-up treatment costs
• Lost income
• Reduced earning capacity
• Physical pain
• Pain and suffering
• Reduced quality of life
• Long-term disability
• Out-of-pocket costs tied to additional care and recovery

TorHoerman Law is reviewing claims from people who received Medtronic spinal cord stimulators and later experienced major complications, painful electrical shocks, device failure, or revision or removal surgery.

These claims may involve allegations that a device intended to alleviate chronic pain instead caused additional treatment, persistent symptoms, or other serious harm after implantation.

Our firm is investigating spinal cord lawsuit claims by reviewing implant records, surgical records, imaging, programming history, and other medical documentation.

That review may help determine whether a patient’s case involves lead migration, device malfunction, inadequate pain relief, or another substantial injury connected to one of these systems.

We understand that patients may be dealing with severe complications after a procedure that was supposed to improve function and reduce pain.

If you believe a Medtronic spinal cord stimulator harmed you, contact TorHoerman Law for a free case review.

You can also use the chatbot on this page to see if you qualify today.